Esker SA
OTC:ESKEF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Esker SA
OTC:ESKEF
|
FR |
|
S
|
Summarecon Agung Tbk PT
XMUN:RZU
|
ID |
|
SJW Group
NASDAQ:HTO
|
US |
|
SkinBioTherapeutics PLC
F:5KW
|
UK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ESKEF's stock price target?
Not Available
ESKEF does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Esker SA?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 4 years is 17%.
What is the Operating Income forecast for Esker SA?
Projected CAGR
32%
Over the last 13 years, the compound annual growth rate for Operating Income has been 19%. The projected CAGR for the next 3 years is 32%.